Trump Administration Backs Down on an Opioid Ban After Kratom Industry Lobbying
New York Times

Health officials will now allow some levels of a powerful substance to remain in products marketed as natural. The change could help a G.O.P. donor facing wrongful death lawsuits.
Summary from New York Times
Read the full story on New York TimesFollow















